{site_meta && site_meta.display_name} Logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

Lexaria (NASDAQ: LEXX) Reports Positive Body Weight Results from Diabetes Animal Study

August 23, 2024Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, is reporting on 8-week body weight results from its ongoing animal study WEIGHT-A24-1. According to the company, this is the only study carried out anywhere in the world today to evaluate the relative performance of liraglutide processed with DehydraTECH. The results show that […]


Clene’s (NASDAQ: CLNN) CNM-Au8(R) Affects Key Biomarkers, Long-term Survival in ALS Trials

August 23, 2024Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, announced positive results of two independently conducted Phase 2 clinical trials, RESCUE-ALS and HEALEY ALS Platform Trials, of CNM-Au8 for the treatment of amyotrophic lateral sclerosis (“ALS”) (https://ibn.fm/ktu4u). The new CNM-Au8 biomarker and clinical […]


Clene’s (NASDAQ: CLNN) CNM-Au8(R) Affects Key Biomarkers, Long-term Survival in ALS Trials

August 23, 2024Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, announced positive results of two independently conducted Phase 2 clinical trials, RESCUE-ALS and HEALEY ALS Platform Trials, of CNM-Au8 for the treatment of amyotrophic lateral sclerosis (“ALS”) (https://ibn.fm/ktu4u). The new CNM-Au8 biomarker and clinical […]


Lexaria (NASDAQ: LEXX) Announces Positive Interim Animal Study Results on DehydraTECH-CBD in Diabetes Control

August 22, 2024Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced receipt of blood glucose results from weeks 4 and 8 of its ongoing animal study WEIGHT-A24-1. The study is underway using diabetic, pre-conditioned Zucker rats. The results showed that DehydraTECH-liraglutide (Group H) and two DehydraTECH-CBD formulations (Groups A and B) were […]


InMed Pharmaceuticals (NASDAQ: INM) Announces Three U.S. Patent Issuances

August 22, 2024InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary small molecule drug candidates, today announced its receipt of three patents granted in the U.S., strengthening its patent portfolio. The issued patents include one for its formulation and method of use in the treatment of epidermolysis bullosa and […]


Scinai Immunotherapeutics (NASDAQ: SCNI), EIB Close on Loan Restructuring Agreement

August 22, 2024Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and on providing contract development and manufacturing organization (“CDMO”) services through its Scinai Bioservices business unit, has closed on its previously announced loan restructuring agreement. According to the announcement, the agreement is with the European Investment Bank (“EIB”) and includes […]


Mullen (NASDAQ: MULN) Subsidiary to Begin Production of All-New Class 4 Commercial Truck in September

August 22, 2024Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that Bollinger Motors, its subsidiary, intends to begin production of saleable units of the Bollinger B4 Chassis Cab, an all-new Class 4 commercial EV truck, on September 16, 2024. Bollinger Motors is partnering on production with Roush Industries, which provides contract manufacturing services from […]


Mullen (NASDAQ: MULN) Subsidiary to Begin Production of All-New Class 4 Commercial Truck in September

August 22, 2024Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that Bollinger Motors, its subsidiary, intends to begin production of saleable units of the Bollinger B4 Chassis Cab, an all-new Class 4 commercial EV truck, on September 16, 2024. Bollinger Motors is partnering on production with Roush Industries, which provides contract manufacturing services from […]


D-Wave Quantum (NYSE: QBTS) Reports Strong Q2 2024 Results

August 22, 2024D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, and the first commercial provider of quantum computers, released its second quarter 2024 financial results along with recent business and technical updates. The company reported growth in key areas, reflecting its continued momentum in the quantum computing market (https://ibn.fm/DNZ11). D-Wave has made […]


D-Wave Quantum (NYSE: QBTS) Reports Strong Q2 2024 Results

August 22, 2024D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, and the first commercial provider of quantum computers, released its second quarter 2024 financial results along with recent business and technical updates. The company reported growth in key areas, reflecting its continued momentum in the quantum computing market (https://ibn.fm/DNZ11). D-Wave has made […]


Scinai Immunotherapeutics (NASDAQ: SCNI) Enters Into $2M Investment Commitment Agreement

August 21, 2024Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices business unit, has entered into a $2 million Investment Commitment Agreement with RK Stone Miami LLC, an affiliate of the largest shareholder of the company, Mr. Daniel Stone. Under the terms […]


InMed Pharmaceuticals (NASDAQ: INM) Announces Exciting INM-901 Data

August 21, 2024InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, today announced that recent data from preclinical studies confirms INM-901, a proprietary small molecule drug candidate, as an oral formulation that will be utilized in the company’s development programs for Alzheimer’s disease. The data shows that […]


Annovis Bio (NYSE: ANVS) CEO Discusses Findings of Buntanetap Alzheimer’s Study on Bell2Bell Podcast

August 21, 2024Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases, presented significant data and findings of its Phase 2/3 Alzheimer’s study of lead drug candidate buntanetap at the Alzheimer’s Association International Conference(R) 2024 (AAIC(R)) in Philadelphia. Dr. Maria Maccecchini, Ph.D., Founder, President, and CEO of the company detailed these […]


McEwen Mining (NYSE: MUX) (TSX: MUX) Closes on Acquisition of Timberline Resources

August 21, 2024McEwen Mining (NYSE: MUX) (TSX: MUX), a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina, has closed on the acquisition of the Timberline Resources Corporation (TSX.V: TBR) (OTCQB: TLRS). The transaction, which was overwhelmingly approved by Timberline shareholders during an Aug. 16, 2024, special meeting, involved the acquisition of all issued and […]


McEwen Mining (NYSE: MUX) (TSX: MUX) Closes on Acquisition of Timberline Resources

August 21, 2024McEwen Mining (NYSE: MUX) (TSX: MUX), a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina, has closed on the acquisition of the Timberline Resources Corporation (TSX.V: TBR) (OTCQB: TLRS). The transaction, which was overwhelmingly approved by Timberline shareholders during an Aug. 16, 2024, special meeting, involved the acquisition of all issued and […]


SuperCom (NASDAQ: SPCB) Releases Q2 2024 Financial Results, Highlighted by Record Profit

August 20, 2024SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-government, Internet of Things (“IoT”) and cybersecurity sectors, is reporting its financial results for second-quarter 2024, the period ended June 30, 2024. Highlights of the report include revenue of $7.5 million, record net income totaling $2.2 million and positive operating cash flow reaching $2 […]


Lexaria Bioscience (NASDAQ: LEXX) Reports on Positive Results from Molecular Characterization Study

August 20, 2024Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has released a report noting the positive findings from its applied research program. The program, which evaluated important mode of action facets of DehydraTECH(TM) processed with semaglutide, the glucagon-peptide 1 (“GLP-1”) drug, was conducted with the National Research Council of Canada (“NRC”). According to […]


SenesTech (NASDAQ: SNES) Offers a Sustainable Solution to the Rodent Problem

August 20, 2024In 2023, it was estimated that New York City had roughly 3 million rats, an increase of almost 1 million over the last ten years. The situation has gotten so bad that the city has become almost synonymous with rat infestation problems. This statistic paints an astonishing picture of the rodent problem in the U.S., […]


Mullen Automotive (NASDAQ: MULN) Continues to Expand Presence in Higher Education Sector

August 20, 2024Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced the sale of the Mullen THREE, Class 3 EV box truck uplift to the facilities operations unit at Princeton University. The Mullen THREE is expected to support the unit’s campus operations as well as contribute to its overall sustainability goals, including reaching zero emissions […]


Mullen Automotive (NASDAQ: MULN) Continues to Expand Presence in Higher Education Sector

August 20, 2024Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced the sale of the Mullen THREE, Class 3 EV box truck uplift to the facilities operations unit at Princeton University. The Mullen THREE is expected to support the unit’s campus operations as well as contribute to its overall sustainability goals, including reaching zero emissions […]